Therapeutic angiogenesis

Cardiology in Review

Volumn 8, Issue 5, 2000, Pages 279-287

  Durairaj, A ^a   Mehra, A ^a   Singh, R P ^a   Faxon, D P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Angina; Angiogenesis; Coronary artery disease; Growth factors

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR;

ANGIOGENESIS; ARTICLE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; MORBIDITY; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; TREATMENT INDICATION;

EID: 0033856444     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045415-200008050-00007     Document Type: Article

References (84)

1. Direct myocardial revascularization and angiogenesis: How many patients might be eligible?
2. Vasculogenesis
3. Mechanisms of angiogenesis
4. Differentiation of endothelium
5. Embryonic development of the vascular system
6. Molecular mechanisms of vasculogenesis and embryonic angiogenesis
7. Angiogenesis
8. Manipulating angiogenesis: From basic science to the bedside
9. Seminars in Medicine of the Beth Israel Hospital, Boston: Clinical applications of research on angiogenesis
10. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis
11. Mechanisms of neovascularization: Vascular sprouting can occur without proliferation of endothelial cells
12. Angiogenesis
13. Collateral circulation of the heart
14. Shear stress-mediated changes in the expression of leukocyte adhesion receptors on human umbilical vein endothelial cells in vitro
15. Shear stress and cyclic strain modulation of gene expression in vascular endothelial cells
16. The endothelial surface of growing coronary collateral arteries: Intimal margination and diapedesis of monocytes - A combined SEM and TEM study
17. The effect of fluid shear stress on the migration and proliferation of cultured endothelial cells
18. Control of coronary angiogenesis
19. Molecular mechanisms of coronary collateral vessel growth
20. Stimulation of coronary collateral growth: Current developments in angiogenesis and future clinical applications
21. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
22. Tumor growth neovascularization: An experimental model using rabbit cornea
23. Heparin-affinity purification of a tumor-derived capillary endothelial cell growth factor
24. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
25. Vascular endothelial growth factor is a secreted angiogenic mitogen
26. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
27. The vascular endothelial growth factor family: Proteins which guide the development of the vasculature
28. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
29. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
30. Failure of blood-island formation and vasculogenesis in Flk-l-deficient mice
31. Role of the Fitreceptor tyrosine kinase in regulating the assembly of vascular endothelium
32. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor
33. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice
34. Vascular endothelial growth factor (VEGF) and its receptors
35. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
36. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
37. Identification of a human VPF/VEGF 3[prime] untranslated region mediating hypoxia-induced mRNA stability
38. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
39. Vascular endothelial growth factor, platelet-derived growth factor and insulin-like growth factor simulate angiogenesis in vitro
40. The vascular endothelial growth factor family
41. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia
42. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
43. Hypoxia-induced paracrine regulation of VEGF receptor -expression
44. VEGF(121) induces proliferation of vascular endothelial cells and expression of Flk-1 without affecting lymphatic vessels of the chorioallantoic membrane
45. Different signal transduction properties of KDR and Flt1, two receptors for Vascular endothelial growth factor
46. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor
47. Of worms and men: An evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families
48. Molecular mechanisms of the fibroblast growth factor family
49. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis
50. Enhanced revascularization of the ischemic limb by angiogenic therapy
51. Angiogenic growth factor and revascularization of the ischemic limb Evaluation in a rabbit model
52. Intramuscular administration of vascular endothelial growth factor induces dose-dependant collateral artery augmentation in a rabbit model of chronic limb ischemia
53. Enhanced revascularization after angiogenic stimulation in a rabbit model of bilateral limb ischaemia
54. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor
55. Reduction in stress myocardial ischemia by basic fibroblast growth factor (rFGF-2) in severe ischemic heart disease
56. Catheter-based transendocardial injection of adenoviral VEGF121 offers equivalent gene delivery and protein expression compared to a surgical-based transepicardial injection approach
57. Regional intramyocardial vascular endothelial growth factor (VEGF) gene transfer and expression using a fluoroscopically guided catheter-based technique
58. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
59. Effects of acidic fibroblast growth factor on normal and ischemic myocardium
60. A model to assess interventions to improve collateral blood flow: Continuous administration of agents into the left coronary artery in dogs
61. Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia
62. Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia
63. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model
64. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart
65. Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels
66. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts
67. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation
68. Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: A comparison of angiographic, echocardiographic and coronary flow parameters
69. Local perivascular basic fibroblast growth factor (bFGF) treatment in patients with ischemic heart disease
70. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart
71. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
72. Angiogenic induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
73. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury
74. Vascular endothelial growth factor administration in chronic myocardial ischemia
75. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts
76. VEGF administration in chronic myocardial ischemia in pigs
77. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
78. The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: First clinical results
79. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial
80. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
81. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
82. 121 cDNA to individuals with clinically significant severe coronary artery disease
83. Double blind randomized trial of recombinant human vascular endothelial growth factor (rhVEGF) protein for therapeutic angiogenesis